EYPT - EyePoint Pharmaceuticals Inc. (EYPT) CEO Nancy Lurker on Q1 2022 Earnings Call Transcript
EyePoint Pharmaceuticals, Inc. (EYPT) Q1 2022 Earnings Conference Call May 04, 2022 08:30 AM ET Company Participants George Elston - CFO Nancy Lurker - President and CEO Jay Duker - COO Scott Jones - CCO Conference Call Participants Georgi Yordanov - Cowen Yatin Suneja - Guggenheim Securities Jennifer Kim - Cantor Fitzgerald Yale Jen - Laidlaw & Company Yi Chen - H.C. Wainwright Presentation Operator Good morning. My name is Josh and I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals First Quarter 2022 Financial Results and Recent Corporate Development's Conference Call. There will be a question-and-answer session to follow at the completion of the prepared remarks. Please be advised that this call is being recorded at the company's request. I would now like to turn the call over to George Elston, Chief Financial Officer of EyePoint Pharmaceuticals. George
For further details see:
EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q1 2022 Earnings Call Transcript